Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California
Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California
批准号:
10347120
负责人:
Argentina Elisa Noelle Servin
金额:
$67.57万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-04-23 至 2026-01-31
关键词:
18 year old2019-nCoVAddressAdultAffectAfrican AmericanAreaAwarenessBehaviorBeliefBenefits and RisksBiological FactorsCOVID-19COVID-19 interventionCOVID-19 mortalityCOVID-19 vaccinationCOVID-19 vaccineCaliforniaCenters for Disease Control and Prevention (U.S.)Cessation of lifeCharacteristicsClient satisfactionColorCommunitiesCommunity HealthCommunity OutreachCountryCountyDataEducationFrightGenerationsGeneticGeographic LocationsGovernmentHandwashingHealthHealth PromotionHealthcareHomeHuman RightsImmunizationImmunization ProgramsIndividualInfectionInterventionKnowledgeLatinoLatinxMasksMedicalMethodsModelingNatureNeighborhood Health CenterNot Hispanic or LatinoOccupationsOutcomeParticipantPerceptionPhasePoliciesPopulationPreventionPreventiveProtocols documentationRandomized Controlled TrialsRecommendationRecording of previous eventsReportingResearchSeriesServicesSiteSocial DistanceStrategic PlanningStructureTimeTrustUnited StatesUnited States National Institutes of HealthVaccinationVaccinesVirusVulnerable PopulationsWorld Health Organizationacceptability and feasibilityadverse outcomebasecommunity based participatory researchcontextual factorsdemographicsethnic minority populationevidence baseexperiencefollow-uphealth care availabilityhealth care service utilizationhealth disparityhospitalization ratesimplementation interventionimprovedindicated preventioninfection rateinterestintervention effectintervention refinementpandemic diseaseparticipant retentionpreventracial and ethnicracial minorityracismrecruitsatisfactionscale upsocialsocial exclusionsocial factorssociodemographicsstandard of careuptakevaccine acceptancevaccine accessvaccine hesitancyworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
As of January 2021, the World Health Organization (WHO) reports that 89 million cases of COVID-19 (SARS-
CoV-2) have been confirmed and have resulted in more than 1.9 million deaths globally. Currently, the United
States (U.S.) is the country with the largest number of infections and deaths due to COVID-19, with a total of
22 million infections and 373,167 deaths. Furthermore, early findings that have examined COVID-19
demographics show that racial and ethnic minorities in the U.S. are bearing a disproportionate number of
COVID-19 cases and deaths irrespective of geographic region. While there's no evidence that people of color
(POC) have genetic or biological factors that make them more likely to be affected by COVID-19, they are
more likely to have underlying health conditions, live in multi-generational homes, live in densely populated
areas, have limited access to healthcare, and have jobs that are considered essential and involve interaction
with the public. All of these factors contribute to higher rates of infection and adverse outcomes due to COVID-19. Although COVID-19 preventive behaviors such as hand washing, mask wearing, and social distancing
have been shown to be effective in curbing the spread of the virus, acceptance and uptake of COVID-19
vaccines will be instrumental to ending the pandemic. However, public confidence in vaccination is fragile,
especially among racial and ethnic minorities. To this end, we have formed an intervention working group
comprised of representatives from community and academic organizations to address challenges in COVID-19
vaccination uptake among Latinx and African American (AA) communities in Southern California by using a
community-based participatory research (CBPR) approach. Project 2VIDA! (SARS-CoV-2 Vaccine Intervention
Delivery for Adults in Southern California), is a multilevel intervention to address individual, social, and
contextual factors related to access to, and acceptance of, the COVID-19 vaccine among Latinx and AA adults
(>18 years old) across six highly affected communities in Southeast San Diego. 2VIDA! seeks to implement
and assess a COVID-19 vaccination protocol to increase interest and uptake of COVID-19 vaccine, provide
COVID-19 vaccines in the community, and establish a model for the rapid vaccination of Latino and AA adults
that could be generalizable to other highly affected communities. 2VIDA! builds on our previous CBPR efforts
and centers on conducting COVID-19 community outreach and health promotion, Individual awareness and
education, and linkages to medical and supportive services and offering the COVID-19 vaccine to Latinx and
AA adults (>18 years old) in community health centers (CHC) and mini-vaccination stations in communities
highly impacted by the pandemic in San Diego County.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California
-
批准号:10551898
-
项目类别:
-
资助金额:$58.45万
-
财政年份:2021
-
负责人:Argentina Elisa Noelle Servin
-
依托单位:
Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California
-
批准号:10733348
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2021
-
负责人:Argentina Elisa Noelle Servin
-
依托单位:
Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California
-
批准号:10397166
-
项目类别:
-
资助金额:$59.99万
-
财政年份:2021
-
负责人:Argentina Elisa Noelle Servin
-
依托单位:
Preventing IPV and Reproductive Coercion Among Underserved Adolescents
-
批准号:9894819
-
项目类别:
-
资助金额:$16.11万
-
财政年份:2016
-
负责人:Argentina Elisa Noelle Servin
-
依托单位:
Preventing IPV and Reproductive Coercion Among Underserved Adolescents
-
批准号:9247788
-
项目类别:
-
资助金额:$16.11万
-
财政年份:2016
-
负责人:Argentina Elisa Noelle Servin
-
依托单位:
Preventing IPV and Reproductive Coercion Among Underserved Adolescents
-
批准号:9110075
-
项目类别:
-
资助金额:$13.84万
-
财政年份:2016
-
负责人:Argentina Elisa Noelle Servin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
微米和纳米塑料作用下2019-nCoV抗病毒药物利巴韦林对河蚬的毒性作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:郭晓宇
-
依托单位:
2019-nCoV感染导致人体淋巴细胞减低机制及其对机体免疫功能影响
-
批准号:82030002
-
项目类别:专项基金项目
-
资助金额:135万元
-
批准年份:2020
-
负责人:曹彬
-
依托单位:
基于人口流动大数据的新型冠状病毒(2019-nCoV)输出感染风险及接触网络传播模型研究
-
批准号:--
-
项目类别:--
-
资助金额:135万元
-
批准年份:2020
-
负责人:吕欣
-
依托单位:
云南驯养野生动物中新型冠状病毒(2019-nCoV)溯源调查与验证
-
批准号:--
-
项目类别:--
-
资助金额:140万元
-
批准年份:2020
-
负责人:夏雪山
-
依托单位:
新型冠状病毒(2019-nCoV)反向遗传系统及啮齿类感染模型的建立与应用
-
批准号:--
-
项目类别:--
-
资助金额:150万元
-
批准年份:2020
-
负责人:黄耀伟
-
依托单位:
血必净预防2019-nCoV肺炎发生ARDS及机制研究
-
批准号:82041003
-
项目类别:专项基金项目
-
资助金额:135万元
-
批准年份:2020
-
负责人:宋元林
-
依托单位:
新型冠状病毒2019-nCoV复制复合体关键蛋白的功能与潜在药物靶点研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:郭德银
-
依托单位:
2019-nCoV蝙蝠及人群代表性流行株致病能力的比较研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:周鹏
-
依托单位:
人新型冠状病毒2019-nCoV受体利用介导的种间传播和感染机制研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:140万元
-
批准年份:2020
-
负责人:葛行义
-
依托单位:
2019-nCoV“不典型症状”感染者的宿主因素及其作用机制研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:张文宏
-
依托单位: